Review Article
Bifidobacterium Longum: Protection against Inflammatory Bowel Disease
Table 1
Effects of B. longum strains in modulating inflammation based on in vitro and ex vivo studies.
| Strains | Dose | Cell | Effect | Ref. |
| B. longum CECT-7347 | cells/mL | HT-29 cell | IL-8 ↓ | [62] | B. longum Bif10 and Bif16 | CFU/mL | RAW264.7 cell | TNF-α, IL-1β, IL-6 ↓ SCFA ↑ | [59] | B. longum BB536 | cells/mL | PIE cell | TNF-α↓ | [60] | B. longum KACC 91563 | , 107, 108 CFU/well | Splenocytes macrophages | TNF-α ↓, IgE ↓ IL-2, 4, 6, 10, IFN-γ ↓ | [51] | B. longum R0033 | 100 : 1 for bacteria to cell ratio | HT-29 cell | TNF-α, IL-8 ↓ | [61] | B. longum 51A | , 105 CFU/well | Keratinocyte fibroblast cell | IL-6, IL-8 ↓ | [73] | B. longum BL05 | , 105, 106 CFU/well | HT-29 cell THP-1 cell | IL-10 ↑ IL-1β, IL-6 ↓ | [67] | B. longum LC67 | , 105 CFU/mL | KATO III cells | NF-κB ↓ IL-8 ↓ | [41] | B. longum LC67 | , 106 CFU/mL | Caco-2 cells | NF-κB ↓ | [28, 74] |
|
|